Nationwide Fund Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-30,552
| Closed | -$1.77M | – | 122 |
|
|
2017
Q3 | $1.77M | Sell |
30,552
-856
| -3% | -$49.6K | 0.01% | 1498 |
|
|
2017
Q2 | $1.55M | Buy |
31,408
+9,780
| +45% | +$483K | 0.01% | 1547 |
|
|
2017
Q1 | $940K | Sell |
21,628
-237
| -1% | -$10.3K | ﹤0.01% | 1788 |
|
|
2016
Q4 | $1.07M | Buy |
21,865
+377
| +2% | +$18.5K | ﹤0.01% | 1735 |
|
|
2016
Q3 | $1.03M | Sell |
21,488
-830
| -4% | -$39.7K | ﹤0.01% | 1770 |
|
|
2016
Q2 | $1.2M | Sell |
22,318
-1,167
| -5% | -$62.6K | 0.01% | 1616 |
|
|
2016
Q1 | $1.07M | Sell |
23,485
-533
| -2% | -$24.2K | ﹤0.01% | 1684 |
|
|
2015
Q4 | $917K | Buy |
24,018
+998
| +4% | +$38.1K | ﹤0.01% | 1775 |
|
|
2015
Q3 | $733K | Buy |
23,020
+13,516
| +142% | +$430K | ﹤0.01% | 1888 |
|
|
2015
Q2 | $314K | Sell |
9,504
-1,102
| -10% | -$36.4K | ﹤0.01% | 2487 |
|
|
2015
Q1 | $437K | Sell |
10,606
-407
| -4% | -$16.8K | ﹤0.01% | 2302 |
|
|
2014
Q4 | $449K | Sell |
11,013
-148
| -1% | -$6.03K | ﹤0.01% | 2240 |
|
|
2014
Q3 | $409K | Buy |
11,161
+94
| +0.8% | +$3.45K | ﹤0.01% | 2321 |
|
|
2014
Q2 | $513K | Buy |
+11,067
| New | +$513K | ﹤0.01% | 2247 |
|
|
2014
Q1 | – | Sell |
-11,439
| Closed | -$437K | – | 3103 |
|
|
2013
Q4 | $437K | Sell |
11,439
-20,616
| -64% | -$788K | ﹤0.01% | 2298 |
|
|
2013
Q3 | $768K | Buy |
32,055
+20,658
| +181% | +$495K | ﹤0.01% | 1985 |
|
|
2013
Q2 | $194K | Buy |
+11,397
| New | +$194K | ﹤0.01% | 2495 |
|